WealthManagement Magazine

Wall Street's Poison

Marijuana is increasingly the drug of choice for those who work at finance firms.

Marijuana is increasingly the drug of choice for those who work at finance firms, not cocaine, according to a review of data compiled by drug testing firm Sterling Infosystems, says The Wall Street Journal. In fact, in 2009, cocaine was found in 7 percent of positive tests at Wall Street firms, down from 16 percent in 2007. By comparison, marijuana was found in 80 percent of failed tests, up from 64 percent in 2007.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish